Real-time enrollment status for this episodic migraine clinical trial
Current Status
Recruiting
Checked: July 18, 2026 at 4:35 PM UTC
| NCT Number | NCT07018700 |
| Recruiting Status | Recruiting |
| Condition | Episodic Migraine |
| Phase | PHASE3 |
| Target Enrollment | 990 participants |
| Active Locations | 46 sites in the US |
| Sponsor | Merz Therapeutics GmbH |
| Last Updated on CT.gov | June 25, 2026 (3 weeks ago) |
As of July 18, 2026: Clinical trial NCT07018700 is currently recruiting participants. This phase3 study for episodic migraine is actively seeking new participants at 46 locations across the United States. The study is sponsored by Merz Therapeutics GmbH. This status information is automatically verified from the official ClinicalTrials.gov registry.
Yes, NCT07018700 is actively recruiting participants as of July 18, 2026. You can check eligibility and apply through HelloStudys.
This trial is recruiting at 46 locations in the United States. View all available locations on the full study page.
Check your eligibility and express interest by completing the application form on the study page. A research coordinator will follow up to discuss next steps.
The official ClinicalTrials.gov record for NCT07018700 was last updated 3 weeks ago (June 25, 2026). HelloStudys verifies this status automatically.